A First Class stamp keflex for cat bite Professor Carole Longson, Health Technology Evaluation Centre Director at NICE, said: Nice is pleased to recommend ranibizumab as a treatment option for some people with visual impairment caused by diabetic macular oedema in new draft guidance.”